7.9. Lumbar Puncture
Subjects with symptoms of central nervous system malignancy such as new onset severe headaches, neck stiffness, or any focal neurologic findings on physical exam will have lumbar puncture performed at the screening visit for examination of cerebral spinal fluid.  In addition, lumbar puncture may be performed as applicable for subjects with new onset of â‰¥ Grade 2 neurologic toxicities after axicabtagene ciloleucel infusion (see Section 6.4). CCI Phase 2 Safety Management Study For subjects enrolled in Cohort 3, Cohort 4, Cohort 5, or Cohort 6, lumbar punctures for the collection of CSF samples will be performed pre- and post-axicabtagene ciloleucel infusion at times outlined in the SOA.  Samples will be submitted to the central laboratory as outlined in the central laboratory manual.  Adequate platelet support should be provided prior to performing a lumbar puncture (e.g. platelet >50,000/mm3).